FDA clearance granted to Penumbra for Indigo Aspiration System

Penumbra has announced FDA 510(k) clearance for expanded indication of its Indigo aspiration system. As part of the system, Indigo aspiration catheters and separators are indicated for the removal of fresh, soft emboli and thrombi from vessels of the peripheral arterial and venous systems, and now for the treatment of pulmonary embolism. Penumbra introduced [...]

2020-01-15T14:49:07+00:00January 15th, 2020|Tags: , , |

Further innovation and research is required for thrombus aspiration in PCI

S Jay Mathews The TASTE and TOTAL studies suggested that routine thombus aspiration in patients undergoing percutaneous coronary intervention (PCI) did not provide mortality benefit and may increase the risk of stroke. However, a new study (CHEETAH) is evaluating whether a next-generation aspiration catheter could lead to improved outcomes. S Jay Mathews [...]

2019-11-21T09:38:40+00:00November 20th, 2019|Tags: , , |

First patient enrolled in study of CAT RX aspiration catheter for thrombus removal in coronary vessels

CAT RX Penumbra has announced the enrolment of the first patient in its CHEETAH study, a prospective, multicentre US study to evaluate the safety and performance of the Indigo system with CAT RX aspiration catheter in the coronary vessels. Introduced in 2018, as part of the Indigo aspiration system, the Indigo CAT [...]

2019-10-15T13:26:19+00:00October 15th, 2019|Tags: , |

Penumbra Jet 7 reperfusion catheter now available in the USA

Jet 7 Penumbra has announced the US commercial availability of its Jet 7 reperfusion catheter, which has “Xtra Flex” technology. According to a press release, the catheter is used with the Penumbra Engine in the fully integrated Penumbra system—an aspiration-based mechanical thrombectomy system that enables physicians to extract thrombus in acute ischaemic stroke [...]

2019-07-30T14:05:08+00:00July 30th, 2019|Tags: , , |
Go to Top